The peculiarities of cancer cell metabolism: A route to metastasization and a target for therapy

被引:17
|
作者
Carvalho, Tiago M. A. [1 ]
Cardoso, Henrique J. [1 ]
Figueira, Marilia I. [1 ]
Vaz, Cada V. [1 ]
Socorro, Silvia [1 ]
机构
[1] UBI, CICS, Hlth Sci Res Ctr, Covilha, Portugal
关键词
Cancer; Metabolism; Metastasization; Therapy; Tumour microenvironment; Metabolic waste; FATTY-ACID SYNTHASE; AUTOCRINE MOTILITY FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; ATP-CITRATE LYASE; HIGH LACTATE LEVELS; PYRUVATE-KINASE M2; HYPOXIA INDUCIBLE FACTORS; SMALL-MOLECULE INHIBITOR; SUPPRESSES TUMOR-GROWTH; ADVANCED OVARIAN-CANCER;
D O I
10.1016/j.ejmech.2019.03.053
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The last decade has witnessed the peculiarities of metabolic reprogramming in tumour onset and progression, and their relevance in cancer therapy. Also, it has been indicated that the metastatic process may depend on the metabolic rewiring and adaptation of cancer cells to the pressure of tumour microenvironment and limiting nutrient availability. The present review gatherers the existent knowledge on the influence of tumour microenvironment and metabolic routes driving metastasis. A focus will be given to glycolysis, fatty acid metabolism, glutaminolysis, and amino acid handling. In addition, the role of metabolic waste driving metastasization will be explored. Finally, we discuss the status of cancer treatment approaches targeting metabolism. This knowledge revision will highlight the critical metabolic targets in metastasis and the chemicals already used in preclinical studies and clinical trials, providing clues that would be further exploited in medicinal chemistry research. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:343 / 363
页数:21
相关论文
共 50 条
  • [41] Targeting Both Aberrant Metabolism and Cell Proliferation in Cancer Therapy
    Gibbs, Bettine
    Masamha, Chioniso Patience
    [J]. FASEB JOURNAL, 2017, 31
  • [42] Anti-cancer agents and reactive oxygen species modulators that target cancer cell metabolism
    Ndombera, Fidelis Toloyi
    [J]. PURE AND APPLIED CHEMISTRY, 2017, 89 (09) : 1333 - 1348
  • [43] Potential and importance of metalloproteinases and interleukins in inflammation and metastasization in non-small cell lung cancer
    Pereira, Joao Luis
    Gomes, Monica
    Teixeira, Ana Luisa
    Coelho, Ana
    Rolfo, Christian
    Araujo, Antonio
    [J]. TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 782 - 795
  • [44] Glucose deprivation as new therapeutic approach to target pancreatic cancer cell metabolism
    Tataranni, T.
    Agriesti, F.
    Ruggieri, V.
    Mazzoccoli, C.
    Laurenzana, I.
    Scrima, R.
    Capitanio, N.
    Piccoli, C.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S82 - S82
  • [45] Cell Connections by Tunneling Nanotubes: Effects of Mitochondrial Trafficking on Target Cell Metabolism, Homeostasis, and Response to Therapy
    Vignais, Marie-Luce
    Caicedo, Andres
    Brondello, Jean-Marc
    Jorgensen, Christian
    [J]. STEM CELLS INTERNATIONAL, 2017, 2017
  • [46] Sphingolipid metabolism as a therapeutic target in chemotherapy resistant and hormone therapy resistant breast cancer
    Gestaut, Matthew M.
    Antoon, James W.
    Ponnapakam, Adharsh P.
    Liu, J.
    Burow, Matthew E.
    Foroozesh, Maryam
    Beckman, Barbara S.
    [J]. CANCER RESEARCH, 2010, 70
  • [47] Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism : An Overview of Energy Metabolism and Alternatives For Targeted Cancer Therapy
    Ghasemishahrestani, Zeinab
    Melo Mattos, Larissa Maura
    Tilli, Tatiana Martins
    Souza dos Santos, Andre Luis
    Pereira, Marcos Dias
    [J]. CURRENT MEDICINAL CHEMISTRY, 2021, 28 (18) : 3514 - 3534
  • [48] Polyamine metabolism as target for cancer chemoprevention
    Seiler, N
    Atanassov, CL
    Raul, F
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (05) : 993 - 1006
  • [49] WRAP53 promotes cancer cell survival and is a potential target for cancer therapy
    Mahmoudi, S.
    Henriksson, S.
    Farnebo, L.
    Roberg, K.
    Farnebo, M.
    [J]. CELL DEATH & DISEASE, 2011, 2 : e114 - e114
  • [50] Stem Cell Factor LIFted as a Promising Clinical Target for Cancer Therapy
    Shi, Yu
    Hunter, Sean
    Hunter, Tony
    [J]. MOLECULAR CANCER THERAPEUTICS, 2019, 18 (08) : 1337 - 1340